Do anticoagulants or antiplatelet drugs have a role in treating heart failure in the absence of atrial fibrillation?

Clinical Pharmacology and Therapeutics

Volumn 94, Issue 4, 2013, Pages 435-438

  Gouda, P ^a   Ezekowitz, J A ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APIXABAN; CLOPIDOGREL; DABIGATRAN; RIVAROXABAN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; CARDIAC PATIENT; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DRUG EFFICACY; DRUG SAFETY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE FUNCTION; HUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SINUS RHYTHM;

ANTICOAGULANTS; ATRIAL FIBRILLATION; HEART FAILURE; HUMANS; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; STROKE;

EID: 84884488384     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.133     Document Type: Review

References (10)

1. Writing Group Members: Roger, V.L. et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125, e2-e220, 2012.
2. Ezekowitz, J.A., Kaul, P., Bakal, J.A., Quan, H. & McAlister, F.A. Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics? Eur. J. Heart Fail. 13, 142-147, 2011.
3. Gage, B.F. et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285, 2864-2870, 2001. (Pubitemid 32537350)
4. Win, S. Morbidity and mortality in diabetics with heart failure and a preserved ejection fraction: results from the I-PRESERVE trial. J. Am. Coll. Cardiol. 61, E706, 2013.
5. McMurray, J.J.V. et al. Left ventricular systolic dysfunction, heart failure and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial. Circ. Heart Fail. 6, 451-460, 2013.
6. Connolly, S.J. et al. Dabigatran versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 361, 1139-1151, 2009.
7. Patel, M.R. et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N. Engl. J. Med. 365, 883-891, 2011.
8. Granger, C.B. et al. Apixaban versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 365, 981-992, 2011.
9. Massie, B.M. et al. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation 119, 1616-1624, 2009.
10. Homma, S. et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. N. Engl. J. Med. 366, 1859-1869, 2012.